118 related articles for article (PubMed ID: 23479594)
1. Antimicrobial resistance presents an "apocalyptic" threat similar to that of climate change, CMO warns.
Torjesen I
BMJ; 2013 Mar; 346():f1597. PubMed ID: 23479594
[No Abstract] [Full Text] [Related]
2. The continuing crisis in antibiotic resistance.
French GL
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S3-7. PubMed ID: 21129629
[TBL] [Abstract][Full Text] [Related]
3. Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital.
Cook PP; Rizzo S; Gooch M; Jordan M; Fang X; Hudson S
J Antimicrob Chemother; 2011 Jan; 66(1):205-9. PubMed ID: 21059617
[TBL] [Abstract][Full Text] [Related]
4. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus.
Dancer SJ; Kirkpatrick P; Corcoran DS; Christison F; Farmer D; Robertson C
Int J Antimicrob Agents; 2013 Feb; 41(2):137-42. PubMed ID: 23276500
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance profiles of common mastitis pathogens on Canadian dairy farms.
Saini V; McClure JT; Léger D; Keefe GP; Scholl DT; Morck DW; Barkema HW
J Dairy Sci; 2012 Aug; 95(8):4319-32. PubMed ID: 22818446
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 1: Prevalence of antimicrobial-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus.
Maddox TW; Clegg PD; Diggle PJ; Wedley AL; Dawson S; Pinchbeck GL; Williams NJ
Equine Vet J; 2012 May; 44(3):289-96. PubMed ID: 21848534
[TBL] [Abstract][Full Text] [Related]
7. Resistance fighters.
Kupferschmidt K
Science; 2016 May; 352(6287):758-61. PubMed ID: 27174968
[No Abstract] [Full Text] [Related]
8. A call to arms: the imperative for antimicrobial stewardship.
Bartlett JG
Clin Infect Dis; 2011 Aug; 53 Suppl 1():S4-7. PubMed ID: 21795727
[TBL] [Abstract][Full Text] [Related]
9. Sanitary status and incidence of methicillin-resistant Staphylococcus aureus and Clostridium difficile within Canadian hotel rooms.
Xu C; Weese SJ; Namvar A; Warriner K
J Environ Health; 2015 Apr; 77(8):8-15. PubMed ID: 25876260
[TBL] [Abstract][Full Text] [Related]
10. The anticancer drug tirapazamine has antimicrobial activity against Escherichia coli, Staphylococcus aureus and Clostridium difficile.
Shah Z; Mahbuba R; Turcotte B
FEMS Microbiol Lett; 2013 Oct; 347(1):61-9. PubMed ID: 23888874
[TBL] [Abstract][Full Text] [Related]
11. [Recent trend and research issues related to antimicrobial-resistant bacteria].
Yamane K; Arakawa Y
Masui; 2010 Jan; 59(1):4-16. PubMed ID: 20077765
[TBL] [Abstract][Full Text] [Related]
12. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital.
Lee AS; Macedo-Vinas M; François P; Renzi G; Vernaz N; Schrenzel J; Pittet D; Harbarth S
J Hosp Infect; 2011 Apr; 77(4):360-2. PubMed ID: 21276638
[No Abstract] [Full Text] [Related]
13. In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams.
Chaudhary M; Kumar S; Payasi A
J Antibiot (Tokyo); 2013 Aug; 66(8):495-7. PubMed ID: 23612723
[No Abstract] [Full Text] [Related]
14. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):217-21. PubMed ID: 23522845
[TBL] [Abstract][Full Text] [Related]
15. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
[TBL] [Abstract][Full Text] [Related]
16. [MRSA and ESBL in outpatient: development from 2008 up to 2012 and socio demographic differences].
Eckmanns T; Richter D; Feig M
Berl Munch Tierarztl Wochenschr; 2014; 127(9-10):399-402. PubMed ID: 25868167
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital.
Cook PP; Gooch M
Int J Antimicrob Agents; 2015 Mar; 45(3):262-7. PubMed ID: 25554468
[TBL] [Abstract][Full Text] [Related]
18. Current challenges in antimicrobial resistance and healthcare-associated infections: role and organization of ARHAI.
Finch R
J Antimicrob Chemother; 2012 Jul; 67 Suppl 1():i3-10. PubMed ID: 22855877
[TBL] [Abstract][Full Text] [Related]
19. The antibiotic challenge: changing clinical management of infections.
Deasy J
JAAPA; 2009 May; 22(5):22-6. PubMed ID: 19469387
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguchi O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Aug; 59(4):217-315. PubMed ID: 17111595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
